DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,571,000 | -46.8% | 77,944 | -1.4% | 0.00% | -50.0% |
Q2 2021 | $2,951,000 | +38.7% | 79,063 | -5.0% | 0.00% | +33.3% |
Q1 2021 | $2,128,000 | +8.7% | 83,217 | -6.3% | 0.00% | 0.0% |
Q4 2020 | $1,957,000 | +21.0% | 88,831 | -1.2% | 0.00% | 0.0% |
Q3 2020 | $1,618,000 | -38.0% | 89,934 | -12.4% | 0.00% | -25.0% |
Q2 2020 | $2,609,000 | +83.3% | 102,697 | +32.6% | 0.00% | +33.3% |
Q1 2020 | $1,423,000 | -13.7% | 77,443 | +3.5% | 0.00% | 0.0% |
Q4 2019 | $1,648,000 | +57.9% | 74,804 | +2.9% | 0.00% | +50.0% |
Q3 2019 | $1,044,000 | -8.2% | 72,690 | +0.7% | 0.00% | 0.0% |
Q2 2019 | $1,137,000 | +10.7% | 72,163 | +3.0% | 0.00% | 0.0% |
Q1 2019 | $1,027,000 | +43.0% | 70,078 | +4.3% | 0.00% | 0.0% |
Q4 2018 | $718,000 | +15.6% | 67,192 | +65.1% | 0.00% | +100.0% |
Q3 2018 | $621,000 | +19.0% | 40,709 | -4.4% | 0.00% | 0.0% |
Q2 2018 | $522,000 | +569.2% | 42,601 | +194.6% | 0.00% | – |
Q1 2016 | $78,000 | -54.7% | 14,463 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $172,000 | +59.3% | 14,463 | +10.3% | 0.00% | – |
Q3 2015 | $108,000 | -38.3% | 13,108 | +4.7% | 0.00% | -100.0% |
Q2 2015 | $175,000 | – | 12,515 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |